000048452 001__ 48452
000048452 005__ 20240122154813.0
000048452 0247_ $$2doi$$a10.1186/1758-5996-6-135
000048452 0248_ $$2sideral$$a94403
000048452 037__ $$aART-2014-94403
000048452 041__ $$aeng
000048452 100__ $$0(orcid)0000-0003-1444-7949$$aVidal Peracho, Concepción
000048452 245__ $$aA descriptive study of health status and quality of life in selected outpatients with type 2 diabetes, pathological body mass index and cardiovascular risk in Spain.
000048452 260__ $$c2014
000048452 5060_ $$aAccess copy available to the general public$$fUnrestricted
000048452 5203_ $$aBackground: Ottawa Charter defined health as a resource for everyday life and as an important dimension of
health related quality of life (HRqol). Diabetes and obesity have repeatedly been shown as diseases that diminish
health status and HRqol. The aim of this study was to measure health status and HRqol in a Spanish sample of
obese patients with type 2 diabetes at cardiovascular risk and analyze behavioural, biological and social
determinants of health.
Methods: Outpatients from external specialized clinic in Endocrinology were evaluated. Measurements: sex, age,
family history, employment status, comorbidities, pain, lifestyle habits, anthropometrics, blood pressure, blood
analysis and HRqol with COOP/WONCA questionnaire (7 dimensions). Statistics: univariate, bivariate, multivariate and
comparative analysis.
Results: Mean age was 59.1 ± 7.6 [95%IC: 56.6-61.6], 74% were women and 63.2% were physically active. WONCA
values were; summary index (SI): 18.7 ± 4 [95%IC: 17.3-20] (maximum 35); physical fitness: 3.3 ± 1, feelings: 2.3 ± 1.1,
social activities: 1.5 ± 1, daily activities: 2.1 ± 1.2, change in health: 2.7 ± 0.9, overall health: 3.6 ± 0.7 and pain: 3.5 ± 1.2
(maximum 5). High fibrinogen values (339.3 ± 85.8 [95%IC: 309.8-368.8]) negatively influenced pain visual analogic
scale (p = 0.029). Physically active patients (63.2%) had better values in daily activities dimension (p = 0.025). More
than the half of the sample (51.5%) reported a good quality of sleep, but the pain worsened it (p = 0.040). High BMI
values (34.8 ± 5.8 [95%IC: 32.9-36.7]) harmed the COOP-WONCA SI (p = 0.009). High glycated hemoglobin (HbA1c)
values (6.8 ± 1.3 [95%IC: 6.3-7.2]) had a negative impact on COOP-WONCA SI (p = 0.018). Nor tailored diet (15.8%) or
being employed (18.4%) influenced the HRqol. The regression that best models COOP-WONCA SI was adjusted for
BMI and HbA1c. SI = 3.509 + 0.335BMI +0.330HbA1c.
Conclusions: HRqol was worse than in general population, but better than in previous studies of diabetes patients,
without differences by sex or age, though feelings, daily activities and pain dimensions scored worse than in these
studies.
Higher levels of HbA1c, obesity and procoagulative state had a negative impact in these last dimensions. Pain
impaired quality of sleep and physical activity had a positive impact in daily activities. BMI and HbA1c modeled the
HRqol.
Keywords: Diabetes mellitus, Type 2, Obesity, Cardiovascular risk, Health related quality of life, Health status
000048452 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000048452 590__ $$a2.173$$b2014
000048452 591__ $$aENDOCRINOLOGY & METABOLISM$$b82 / 128 = 0.641$$c2014$$dQ3$$eT2
000048452 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000048452 700__ $$0(orcid)0000-0002-9930-3903$$aLucha López, María Orosia$$uUniversidad de Zaragoza
000048452 700__ $$0(orcid)0000-0002-8399-130X$$aLucha López, Ana Carmen$$uUniversidad de Zaragoza
000048452 700__ $$0(orcid)0000-0002-3583-5206$$aTricás Moreno, José Miguel$$uUniversidad de Zaragoza
000048452 700__ $$0(orcid)0000-0002-5161-7479$$aEstébanez De Miguel, Elena$$uUniversidad de Zaragoza
000048452 700__ $$0(orcid)0000-0002-6408-5328$$aBernués Vázquez, Luis Máximo$$uUniversidad de Zaragoza
000048452 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería
000048452 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000048452 773__ $$g6 (2014), 135$$pDIABETOLOGY & METABOLIC SYNDROME$$tDIABETOLOGY & METABOLIC SYNDROME$$x1758-5996
000048452 8564_ $$s783806$$uhttps://zaguan.unizar.es/record/48452/files/texto_completo.pdf$$yVersión publicada
000048452 8564_ $$s99640$$uhttps://zaguan.unizar.es/record/48452/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000048452 909CO $$ooai:zaguan.unizar.es:48452$$particulos$$pdriver
000048452 951__ $$a2024-01-22-15:30:46
000048452 980__ $$aARTICLE